Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug shows promise for managing short bowel syndrome Long-Term

NCT ID NCT07228403

Ongoing Disease control Sponsor: Zealand Pharma Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 2 times

Summary

This study looks at the long-term safety and effectiveness of a drug called glepaglutide in adults with short bowel syndrome (SBS), a condition where the body can't absorb enough nutrients from food. Participants who were already in earlier trials can continue treatment for up to 2 years. The goal is to see if the drug helps reduce the need for intravenous nutrition support and is safe over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SHORT BOWEL SYNDROME (SBS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Digestive System Diseases digestive system disorder intestinal disorder malabsorption syndrome Pathologic Processes Pathological Conditions, Signs and Symptoms Postoperative Complications short bowel syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SHORT BOWEL SYNDROME (SBS)

Contacts and locations

Locations

  • AP-HP - Hôpital Beaujon

    Clichy, Hauts-de-Seine, 92118, France

  • Asklepios Klinik St. Georg

    Hamburg, 20099, Germany

  • Charité - Universitätsmedizin Berlin

    Berlin, State of Berlin, 10117, Germany

  • Cleveland Clinic-9500 Euclid Ave

    Cleveland, Ohio, 44195-0001, United States

  • LHSC - University Hospital

    London, Ontario, N6A 4V2, Canada

  • Lied Transplant Center at Nebraska Medical Center

    Omaha, Nebraska, 68105, United States

  • Mayo Clinic - PPDS

    Rochester, Minnesota, 55905-0001, United States

  • Samodzielny Publiczny Szpitala Kliniczny im. Prof. Witolda Orlowskiego CMKP

    Warsaw, Masovian Voivodeship, 00-416, Poland

  • St Mark's Hospital (Central Middlesex Hospital)

    Ealing, NW10 7NS, United Kingdom

  • Szpital Skawina sp. z o.o. im. Stanley Dudricka

    Skawina, Lesser Poland Voivodeship, 32-050, Poland

  • UZ Leuven - PPDS

    Leuven, 3000, Belgium

  • Universitätsklinikum Bonn

    Bonn, North Rhine-Westphalia, 53127, Germany

  • Universitätsklinikum Frankfurt

    Frankfurt am Main, Hesse, 60590, Germany

  • Universitätsmedizin Rostock

    Rostock, Mecklenburg-Vorpommern, 18057, Germany

  • Vanderbilt University Medical Center-Tennesse-1211 21st Ave S

    Nashville, Tennessee, 37212-2700, United States

  • Wojewódzki Szpital Specjalistycznyo im. M. Pirogowa w Lodzi

    Lodz, 90-531, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.